GLP-1 weight loss results on TikTok: what 22 pounds actually means

What did @betsmarr actually say?

She said she lost 22 pounds in roughly three months on a GLP-1 medication, that her only real side effect is nausea the morning after her injection, and that eating "a piece of banana" helps manage it. She also mentioned she takes her shot at night, near her belly button, and has her partner administer it because she can't inject herself.

She's promoting a telehealth platform called LifeRx.md with a discount code, which means this is a paid or affiliate partnership. That doesn't automatically make her claims false, but it's worth keeping that context in mind before treating this as neutral health information. She didn't name the specific drug, but the hashtag glp1forweightloss and the injection format point to semaglutide or tirzepatide.

Does the science back this up?

The 22-pound loss over three months is plausible and sits within the range seen in clinical trials, though it's on the higher end for that timeframe. The nausea timing she describes is consistent with how GLP-1 receptor agonists actually work.

The STEP 1 trial (Wilding et al., 2021, New England Journal of Medicine) found participants on semaglutide lost an average of 14.9% of body weight over 68 weeks. Three months is early in that curve, so 22 pounds is achievable for someone with higher starting weight but would be above average. Nausea is the most commonly reported adverse event with GLP-1 agonists, occurring in roughly 44% of semaglutide users versus 16% on placebo (Wilding et al., 2021). The fact that her nausea peaks the morning after a nighttime injection aligns with the drug's pharmacokinetics. Subcutaneous injection near the abdomen is a standard administration site confirmed by prescribing guidelines.

What did they get wrong (or right)?

The banana tip is interesting. It's not wrong, but it's also not a studied protocol. Eating a small amount of food to blunt GLP-1-related nausea is a commonly shared patient strategy, and there's a reasonable physiological logic to it since gastric emptying is already slowed. But she's presenting anecdotal management advice as if it's a reliable fix, and that could set unrealistic expectations for people whose nausea is more severe.

She also says the nausea "is really not super bad. It's bad." That contradiction is actually the most honest moment in the video. GLP-1-related nausea can be significant enough that 4.5% of participants in the STEP 1 trial discontinued due to gastrointestinal side effects. Framing it as easily managed with fruit undersells how disruptive it can be for some users.

Having a partner administer the injection is presented as a quirky personal preference. That's fine, but auto-injector pens are specifically designed for self-administration, and the inability to self-inject may be worth discussing with a prescriber rather than just outsourcing the task indefinitely.

What should you actually know?

Three things stand out if you're watching this video and considering a GLP-1 medication.

• Individual results vary widely. A 2022 analysis by Ghusn et al. in Obesity Pillars found that roughly 10% of patients are poor responders to semaglutide, losing less than 5% of body weight. One person's 22-pound success isn't a guarantee of yours.
• Nausea management is real but needs medical input. Strategies like eating small amounts before or after injection, staying hydrated, and timing your dose are legitimate approaches, but persistent or severe nausea should be reported to your prescriber, not treated with fruit.
• This video is promotional. The affiliate code and platform tag mean @betsmarr has a financial relationship with LifeRx.md. That doesn't mean the platform is bad, but her experience is being used as a marketing vehicle, which shapes what she emphasizes and what she leaves out.

GLP-1 medications have solid clinical evidence behind them. The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) showed tirzepatide produced up to 22.5% mean weight loss over 72 weeks. These are real drugs with real effects. They also require real medical oversight, not just a discount code.